GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
GANX fundamentals
Gain Therapeutics (GANX) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.19 (YoY +54.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.19
+54.76%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Gain Therapeutics (GANX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Gain Therapeutics (GANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Gain Therapeutics (GANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Gain Therapeutics (GANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Gain Therapeutics (GANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Gain Therapeutics (GANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Gain Therapeutics’s earnings call?What is the market's earnings forecast for Gain Therapeutics next quarter?What were the key takeaways from Gain Therapeutics's earnings call?What guidance did Gain Therapeutics's management provide for the next earnings period?What factors drove the changes in Gain Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Gain Therapeutics year over year?What does Gain Therapeutics do and what are its main business segments?What is Gain Therapeutics's gross profit margin?
